It has been reported that Galectin-3 silencing inhibits epirubicin-induced ATP binding cassette transporters and activates the mitochondrial apoptosis pathway via β-catenin/GSK-3β modulation in colorectal carcinoma [35]. Here, GSK3B is linked to colorectal carcinoma.